Literature DB >> 30484897

Pathogenesis-targeted therapeutic strategies in Parkinson's disease.

Joseph Jankovic1.   

Abstract

Entities:  

Year:  2018        PMID： 30484897     DOI： 10.1002/mds.27534

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  10 in total

1.  Immunotherapies Targeting α-Synuclein in Parkinson Disease.

Authors:  Fariha Jamal
Journal:  Fed Pract       Date:  2020-08

2.  Slowing Parkinson's Disease Progression with Vaccination and Other Immunotherapies.

Authors:  Dhanya Vijayakumar; Joseph Jankovic
Journal:  CNS Drugs       Date:  2022-02-25       Impact factor: 5.749

Review 3.  New Perspectives on Immune Involvement in Parkinson's Disease Pathogenesis.

Authors:  David Gate
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.

Authors:  Loredana Leggio; Greta Paternò; Silvia Vivarelli; Francesca L'Episcopo; Cataldo Tirolo; Gabriele Raciti; Fabrizio Pappalardo; Carmela Giachino; Salvatore Caniglia; Maria Francesca Serapide; Bianca Marchetti; Nunzio Iraci
Journal:  Biomolecules       Date:  2020-09-16

Review 5.  "Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.

Authors:  Bianca Marchetti; Carmela Giachino; Cataldo Tirolo; Maria F Serapide
Journal:  Aging Cell       Date:  2022-03-09       Impact factor: 9.304

6.  Alpha-Synuclein Clearance through Inhibiting Akt/mTOR Pathway by Microfluidic Encapsulated Induced Conjunctival MSCs in a Parkinsonian Model.

Authors:  Meysam Forouzandeh; Mohammad Reza Bigdeli; Hossein Mostafavi; Samad Nadri; Mehdi Eskandari
Journal:  Iran J Pathol       Date:  2022-08-16

7.  Neuroprotective effects of coenzyme Q10 in Parkinson's model via a novel Q10/miR-149-5p/MMPs pathway.

Authors:  Elham Ghasemloo; Hossein Mostafavi; Masoumeh Hosseini; Meysam Forouzandeh; Mehdi Eskandari; Seyyed Saeid Mousavi
Journal:  Metab Brain Dis       Date:  2021-08-06       Impact factor: 3.584

Review 8.  Parkinson disease and the immune system - associations, mechanisms and therapeutics.

Authors:  Eng-King Tan; Yin-Xia Chao; Andrew West; Ling-Ling Chan; Werner Poewe; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2020-04-24       Impact factor: 42.937

9.  Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis.

Authors:  Maria Francesca Serapide; Francesca L'Episcopo; Cataldo Tirolo; Nunzio Testa; Salvatore Caniglia; Carmela Giachino; Bianca Marchetti
Journal:  Front Aging Neurosci       Date:  2020-03-12       Impact factor: 5.750

Review 10.  Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era.

Authors:  Dunhui Li; Frank L Mastaglia; Sue Fletcher; Steve D Wilton
Journal:  Med Res Rev       Date:  2020-08-06       Impact factor: 12.944
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.